These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8389407

  • 21. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
    Tallett A, Chilvers ER, Hannah S, Dransfield I, Lawson MF, Haslett C, Sethi T.
    Cancer Res; 1996 Sep 15; 56(18):4255-63. PubMed ID: 8797601
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
    Takuwa N, Takuwa Y, Ohue Y, Mukai H, Endoh K, Yamashita K, Kumada M, Munekata E.
    Cancer Res; 1990 Jan 15; 50(2):240-4. PubMed ID: 1688510
    [Abstract] [Full Text] [Related]

  • 24. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
    Layton JE, Scanlon DB, Soveny C, Morstyn G.
    Cancer Res; 1988 Sep 01; 48(17):4783-9. PubMed ID: 2457430
    [Abstract] [Full Text] [Related]

  • 25. Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer.
    Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD, Shriver SP.
    Pulm Pharmacol Ther; 1999 Sep 01; 12(5):291-302. PubMed ID: 10545285
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells.
    Taylor JE, Moreau JP, Baptiste L, Moody TW.
    Peptides; 1991 Sep 01; 12(4):839-43. PubMed ID: 1686316
    [Abstract] [Full Text] [Related]

  • 28. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
    Zhou J, Chen J, Mokotoff M, Zhong R, Shultz LD, Ball ED.
    Clin Cancer Res; 2003 Oct 15; 9(13):4953-60. PubMed ID: 14581370
    [Abstract] [Full Text] [Related]

  • 29. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
    Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL.
    Proc Natl Acad Sci U S A; 1990 Sep 15; 87(17):6698-702. PubMed ID: 2168554
    [Abstract] [Full Text] [Related]

  • 30. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
    Mahmoud S, Palaszynski E, Fiskum G, Coy DH, Moody TW.
    Life Sci; 1989 Sep 15; 44(5):367-73. PubMed ID: 2536883
    [Abstract] [Full Text] [Related]

  • 31. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [Abstract] [Full Text] [Related]

  • 32. Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture.
    Novak J, Escobedo-Morse A, Kelley K, Boose D, Kautzman-Eades D, Meyer M, Kane MA.
    Lung Cancer; 2000 Jul 01; 29(1):1-10. PubMed ID: 10880842
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
    Kiaris H, Schally AV, Nagy A, Sun B, Armatis P, Szepeshazi K.
    Br J Cancer; 1999 Nov 01; 81(6):966-71. PubMed ID: 10576652
    [Abstract] [Full Text] [Related]

  • 35. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
    Moody TW, Zia F, Draoui M, Brenneman DE, Fridkin M, Davidson A, Gozes I.
    Proc Natl Acad Sci U S A; 1993 May 15; 90(10):4345-9. PubMed ID: 8389448
    [Abstract] [Full Text] [Related]

  • 36. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE.
    Cancer Res; 1996 Feb 15; 56(4):831-9. PubMed ID: 8631021
    [Abstract] [Full Text] [Related]

  • 37. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4.
    Conroy DM, Samhoun MN, Piper PJ.
    Br J Pharmacol; 1991 Dec 15; 104(4):1012-8. PubMed ID: 1725762
    [Abstract] [Full Text] [Related]

  • 38. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
    Moody TW, Staley J, Zia F, Coy DH, Jensen RT.
    J Pharmacol Exp Ther; 1992 Oct 15; 263(1):311-7. PubMed ID: 1328611
    [Abstract] [Full Text] [Related]

  • 39. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
    Moody TW, Leyton J, Garcia-Marin L, Jensen RT.
    Eur J Pharmacol; 2003 Aug 01; 474(1):21-9. PubMed ID: 12909192
    [Abstract] [Full Text] [Related]

  • 40. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells.
    Hoosein NM, Logothetis CJ, Chung LW.
    J Urol; 1993 May 01; 149(5):1209-13. PubMed ID: 8097794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.